Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lital Magid

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|March 23, 2011
Endocannabinoids and traumatic brain injuryEsther Shohami, Ayelet Cohen-Yeshurun, Lital Magid, et al.
Journal of Neurotrauma|November 30, 2018
Role of CB<sub>2</sub> Receptor in the Recovery of Mice after Traumatic Brain InjuryLital Magid, Sami Heymann, Merav Elgali, et al.
British Journal of Pharmacology|April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryBėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|March 23, 2011
Endocannabinoids and traumatic brain injuryEsther Shohami, Ayelet Cohen-Yeshurun, Lital Magid, et al.
Journal of Neurotrauma|November 30, 2018
Role of CB<sub>2</sub> Receptor in the Recovery of Mice after Traumatic Brain InjuryLital Magid, Sami Heymann, Merav Elgali, et al.
British Journal of Pharmacology|April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryBėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Pageof 1